Market Tracker

04/25 4:06am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

52.78
Data as of Apr 24
 -1.54 / -2.84%
Today’s Change
22.54
Today|||52-Week Range
112.57
-17.92%
Year-to-Date

Today’s Trading

Previous close54.32
Today’s open54.88
Day’s range-- - --
Volume1,000,123
Average volume (3 months)780,537
Market cap$3.7B
Dividend yield--
Data as of 04/24/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-36.69%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book13.66

Competitors

 Today’s
change
Today’s
% change
ISISIsis Pharmaceuticals...0.000.00%
PRXLPAREXEL Internationa...+0.52+1.07%
CRLCharles River Labora...+0.21+0.37%
ICLRICON PLC+0.12+0.27%
Data as of 04/24/2014

Financials

Next reporting dateMay 5, 2014
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts